Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: Evaluation of suitable purification process conditions

被引:9
作者
Bedu-Addo, FK
Johnson, C
Jeyarajah, S
Henderson, I
Advant, SJ [1 ]
机构
[1] Diosynth RTP Inc, Cary, NC 27513 USA
[2] Dynport Vaccine Co LLC, Frederick, MD 21702 USA
关键词
botulinum neurotoxin; circular dichroism; differential scanning calorimetry; proteins; purification;
D O I
10.1023/B:PHAM.0000036908.70139.f1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this study was to investigate the physicochemical and structural characteristics of recombinant botulinum serotype B (rBoNTB(Hc)) under various conditions and to use the information in evaluating suitable purification process conditions. Methods. The solubility of rBoNTB( Hc) was evaluated at pH 4, 5, 6 7.5, 8, and 9. Secondary structure was evaluated using circular dichroism, and conformational stability was monitored using high-sensitivity differential scanning calorimetry. Hydrophobic interaction chromatography, size exclusion chromatography-high performance liquid chromatography (SEC-HPLC), sodium dodecyl sulfate-poly acrylamide gel electrophoresis (SDS-PAGE), peptide mapping, and UV spectroscopy were used to monitor stability under the various conditions. Results. The secondary structure of rBoNTB( Hc) consists predominantly of beta-sheets. Solubility of rBoNTB( Hc) was lowest at its pI and highest at low and high pH. In the presence of NaCl, however, solubility decreased with increase in pH. Conformational and chemical stability are improved below pH 7.5. In the presence of 150 mM NaCl at high pH, conformational and chemical stability of rBoNTB( Hc) are further decreased. The study suggests that the purification process should minimize exposure of rBoNTB( Hc) to high pH and salt conditions. Conclusions. Optimal stability of rBoNTB( Hc) is achieved at low pH. The biophysical and analytical studies provide us with an understanding of rBoNTB( Hc) stability behavior in solution and assists in developing efficient purification conditions.
引用
收藏
页码:1353 / 1361
页数:9
相关论文
共 27 条
[11]   WW:: An isolated three-stranded antiparallel β-sheet domain that unfolds and refolds reversibly;: evidence for a structured hydrophobic cluster in urea and GdnHCl and a disordered thermal unfolded state [J].
Koepf, EK ;
Petrassi, HM ;
Sudol, M ;
Kelly, JW .
PROTEIN SCIENCE, 1999, 8 (04) :841-853
[12]   Correcting the circular dichroism spectra of peptides for contributions of absorbing side chains [J].
Krittanai, C ;
Johnson, WC .
ANALYTICAL BIOCHEMISTRY, 1997, 253 (01) :57-64
[13]   EXPRESSION OF A LARGE, NONTOXIC FRAGMENT OF BOTULINUM NEUROTOXIN SEROTYPE-A AND ITS USE AS AN IMMUNOGEN [J].
LAPENOTIERE, HF ;
CLAYTON, MA ;
MIDDLEBROOK, JL .
TOXICON, 1995, 33 (10) :1383-1386
[14]   THEORETICAL DETERMINATION OF THE CD OF PROTEINS CONTAINING CLOSELY PACKED ANTIPARALLEL BETA-SHEETS [J].
MANNING, MC ;
WOODY, RW .
BIOPOLYMERS, 1987, 26 (10) :1731-1752
[15]   Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris [J].
Potter, KJ ;
Bevins, MA ;
Vassilieva, EV ;
Chiruvolu, VR ;
Smith, T ;
Smith, LA ;
Meagher, MM .
PROTEIN EXPRESSION AND PURIFICATION, 1998, 13 (03) :357-365
[16]  
SATHYAMOORTHY V, 1985, J BIOL CHEM, V260, P461
[17]   TETANUS AND BOTULINUM NEUROTOXINS ARE ZINC PROTEASES SPECIFIC FOR COMPONENTS OF THE NEUROEXOCYTOSIS APPARATUS [J].
SCHIAVO, G ;
ROSSETTO, O ;
BENFENATI, F ;
POULAIN, B ;
MONTECUCCO, C .
TOXINS AND EXOCYTOSIS, 1994, 710 :65-75
[18]  
Schiavo Giampietro, 1994, Seminars in Cell Biology, V5, P221, DOI 10.1006/scel.1994.1028
[19]  
SIMPSON LL, 1981, PHARMACOL REV, V33, P155
[20]   Development of recombinant vaccines for botulinum neurotoxin [J].
Smith, LA .
TOXICON, 1998, 36 (11) :1539-1548